Argenx
ARGX
$308.98
Share price
-0.86%
Change (1 day)
13.47%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Market capitalization of Argenx (ARGX)
Market cap: $16.75 Billion
As of May 2022 Argenx has a market cap of $16.75 Billion. This makes Argenx the world's 980th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Argenx from 2014 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $17.86 B | -2.87% |
| 2021 | $18.39 B | 31.15% |
| 2020 | $14.02 B | 103.85% |
| 2019 | $6.87 B | 96.18% |
| 2018 | $3.50 B | 74.88% |
| 2017 | $2.00 B | |
| 2014 | $0.14 B |
End of Day market cap according to different sources
On May 15th, 2022 the market cap of Argenx was reported to be:
$16.70 Billion
$17.86 Billion
$16.90 Billion
$16.24 Billion